Phase II study of everolimus (E) in refractory germ cell tumors (GCTs).
Michal Mego
No relevant relationships to disclose
Daniela Svetlovska
No relevant relationships to disclose
Jana Obertova
No relevant relationships to disclose
Maria Reckova
No relevant relationships to disclose
Viera Miskovska
No relevant relationships to disclose
Jan Rajec
No relevant relationships to disclose
Zuzana Sycova-Mila
No relevant relationships to disclose
Patrik Palacka
No relevant relationships to disclose
Stefania Liskova
No relevant relationships to disclose
Michal Chovanec
No relevant relationships to disclose
Tomas Salek
No relevant relationships to disclose
Jozef Mardiak
No relevant relationships to disclose